Senior Research Scientist II
Gilead Sciences, Inc.
Liping Meng, PhD currently holds the position of Senior Scientist II at Gilead Sciences, bringing
over 15 years of managerial expertise in the pharmaceutical and biotech sectors, spanning research,
production, and analytical CMC. Her successful oversight includes more than 20 drug development
projects, guiding them from the initial stages to commercialization. Notably, she played a pivotal
role in the regulatory journey of Sunlenca® (lenacapavir), leading to FDA approval as a groundbreaking, twice-yearly treatment for individuals with multi-drug resistant HIV. Before her current role, Liping held a leadership position at AnaSpec. Prior to that, she conducted research at UC
Davis after completing her doctoral degree in Organic Chemistry from the University of Tuebingen, Germany.